The spleen tyrosine kinase (SYK): A crucial therapeutic target for diverse liver diseases

The spleen tyrosine kinase (SYK): A crucial therapeutic target for diverse liver diseases

Spleen tyrosine kinase (SYK) is an enigmatic protein tyrosine kinase, and involved in signal transduction related with lots of cellular processes. It’s highly expressed in the cells of hematopoietic origin and acts as an important therapeutic target in the treatment of autoimmune diseases and allerg...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän:	Yaping Zhao, Rongrong Liu, Miaomiao Li, Pengfei Liu
Materialtyp:	Artikel
Språk:	English
Publicerad:	Elsevier 2022-12-01
Serie:	Heliyon
Ämnen:	Spleen tyrosine kinase (SYK) Liver diseases Small molecule inhibitor Therapy target
Länkar:	http://www.sciencedirect.com/science/article/pii/S2405844022034181

Liknande verk

The selective inhibition of the Syk tyrosine kinase ameliorates experimental autoimmune arthritis
av: Eszter Káposztás, et al.
Publicerad: (2023-12-01)

Recent advances in understanding spleen tyrosine kinase (SYK) in human biology and disease, with a focus on fostamatinib
av: Nichola Cooper, et al.
Publicerad: (2023-01-01)

Biochemical characterization of spleen tyrosine kinase (SYK) isoforms in platelets
av: Pankaj Kumar Singh, et al.
Publicerad: (2023-12-01)

Activation of spleen tyrosine kinase (SYK) contributes to neuronal pyroptosis and cognitive impairment in diabetic mice via the NLRP3/Caspase-1/GSDMD signaling pathway
av: Chenglong Zhou, et al.
Publicerad: (2024-12-01)

Identification of high-performing antibodies for tyrosine-protein kinase SYK for use in Western Blot, immunoprecipitation and immunofluorescence [version 3; peer review: 2 approved]
av: Carl Laflamme, et al.
Publicerad: (2024-06-01)

Hematopoietic or Osteoclast-Specific Deletion of Syk Leads to Increased Bone Mass in Experimental Mice
av: Dániel Csete, et al.
Publicerad: (2019-04-01)

Spleen tyrosine kinase (SYK) signals are implicated in cardio-cerebrovascular diseases
av: Mohan Li, et al.
Publicerad: (2023-05-01)

Spleen tyrosine kinase mediates the γδTCR signaling required for γδT cell commitment and γδT17 differentiation
av: Ryunosuke Muro, et al.
Publicerad: (2023-01-01)

Characterization of the mechanism of action of lanraplenib, a novel spleen tyrosine kinase inhibitor, in models of lupus nephritis
av: Christopher W. Pohlmeyer, et al.
Publicerad: (2021-03-01)

Anti-microbial cetylpyridinium chloride suppresses mast cell function by targeting tyrosine phosphorylation of Syk kinase
av: Bright Obeng, et al.
Publicerad: (2024-12-01)

Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
av: Kata P. Szilveszter, et al.
Publicerad: (2019-08-01)

S-Layer From Lactobacillus brevis Modulates Antigen-Presenting Cell Functions via the Mincle-Syk-Card9 Axis
av: Mariano Prado Acosta, et al.
Publicerad: (2021-03-01)

A spleen tyrosine kinase inhibitor attenuates the proliferation and migration of vascular smooth muscle cells
av: Hyang‑Hee Seo, et al.

Spleen Tyrosine Kinase Is a Critical Regulator of Neutrophil Responses to <italic toggle="yes">Candida</italic> Species
av: Paige E. Negoro, et al.
Publicerad: (2020-06-01)

Immunomodulatory role of spleen tyrosine kinase in chronic inflammatory and autoimmune diseases
av: Yaqi Zhou, et al.
Publicerad: (2023-07-01)

CCL4‐mediated targeting of spleen tyrosine kinase (Syk) inhibitor using nanoparticles alleviates inflammatory bowel disease
av: Wenbin Gong, et al.
Publicerad: (2021-02-01)

Inhibition of Spleen Tyrosine Kinase Restores Glucocorticoid Sensitivity to Improve Steroid-Resistant Asthma
av: Qian Liu, et al.
Publicerad: (2022-05-01)

Systematic analysis of spleen tyrosine kinase expression and its clinical outcomes in various cancers
av: Akram I Alwithenani, et al.
Publicerad: (2020-01-01)

Phosphorylation of (Ser 291) in the linker insert of Syk negatively regulates ITAM signaling in platelets
av: Carol Dangelmaier, et al.
Publicerad: (2024-12-01)

The rapid inhibition of B-cell activation markers by belimumab was associated with disease control in systemic lupus erythematosus patients
av: Jing Wang, et al.
Publicerad: (2023-02-01)

Expression of variant isoforms of the tyrosine kinase SYK differentially regulates cervical cancer progression through PI3K/AKT pathway
av: Bingjie Lin, et al.
Publicerad: (2024-11-01)

Three Novel Players: PTK2B, SYK, and TNFRSF21 Were Identified to Be Involved in the Regulation of Bovine Mastitis Susceptibility via GWAS and Post-transcriptional Analysis
av: Fan Yang, et al.
Publicerad: (2019-08-01)

Development of SYK NanoBRET cellular target engagement assays for gain–of–function variants
av: Jacob L. Capener, et al.
Publicerad: (2024-07-01)

Effects of a spleen tyrosine kinase inhibitor on progression of the lupus nephritis in mice
av: Maki Kitai, et al.
Publicerad: (2017-05-01)

Mechanisms of acquired resistance to tyrosine kinase inhibitors
av: Yi-fan Chen, et al.
Publicerad: (2011-12-01)

Tyrosine kinase targeting: A potential therapeutic strategy for diabetes
av: Mohammad Althubiti
Publicerad: (2022-01-01)

Spleen tyrosine kinase inhibitors disrupt human neutrophil swarming and antifungal functions
av: Alex Hopke, et al.
Publicerad: (2025-01-01)

Stress Granules Modulate SYK to Cause Microglial Cell Dysfunction in Alzheimer's Disease
av: Soumitra Ghosh, et al.
Publicerad: (2015-11-01)

Fluorescent Tracking of Yeast Division Clarifies the Essential Role of Spleen Tyrosine Kinase in the Intracellular Control of Candida glabrata in Macrophages
av: Zeina Dagher, et al.
Publicerad: (2018-05-01)

Aberrant RON and MET Co-overexpression as Novel Prognostic Biomarkers of Shortened Patient Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Pancreatic Cancer
av: Chen-Yu Hu, et al.
Publicerad: (2019-12-01)

Mechanisms of resistance to tyrosine kinase inhibitor‐targeted therapy and overcoming strategies
av: Xuejin Ou, et al.
Publicerad: (2024-09-01)

Inhibitory effects of regorafenib, a multiple tyrosine kinase inhibitor, on corneal neovascularization
av: Halil Ibrahim Onder, et al.
Publicerad: (2014-04-01)

Receptor Tyrosine Kinase Signaling Involves <i>Echinococcus</i>–Host Intercommunication: A Potential Therapeutic Target in Hepatic Echinococcosis
av: Haijun Gao, et al.
Publicerad: (2024-08-01)

Advances in studies of tyrosine kinase inhibitors and their acquired resistance
av: Qinlian Jiao, et al.
Publicerad: (2018-02-01)

Receptor Tyrosine Kinases and Their Signaling Pathways as Therapeutic Targets of Curcumin in Cancer
av: Sareshma Sudhesh Dev, et al.
Publicerad: (2021-11-01)

Exploring receptor tyrosine kinases-inhibitors in Cancer treatments
av: D. Samuel Metibemu, et al.
Publicerad: (2019-12-01)

Recent developments in receptor tyrosine kinases targeted anticancer therapy
av: Samir H. Raval, et al.
Publicerad: (2016-01-01)

Complement receptor-3 negatively regulates the phagocytosis of degenerated myelin through tyrosine kinase Syk and cofilin
av: Hadas Smadar, et al.
Publicerad: (2012-07-01)

Characterization of acquired receptor tyrosine–kinase fusions as mechanisms of resistance to EGFR tyrosine–kinase inhibitors
av: Xu H, et al.
Publicerad: (2019-07-01)

Therapeutic potential of tyrosine-protein kinase MET in osteosarcoma
av: Ming Zeng, et al.
Publicerad: (2024-03-01)